Download - UNITAID Innovative Financing Mechanism
UNITAID Innovative Financing Mechanism
Denis BrounExecutive Director
80% of UNITAID funds from Air ticket tax• Cameroon• Chile • France + multi year commitment• Republic of Korea• Madagascar• Mauritius• Mali• Niger• More countries soon
Applied to all fights departing from countries • Amount can vary and decided by government
» 1 euro domestic economy » to 40 euros business international
• Neutral (all companies) No negative impact
• Norway – Co2 emission tax
20% multi budgetary contributions• UK + multi year commitment• Spain• Cyprus• Brazil + multi year commitment• Gates Foundation
Over US$ 2 billion raised since 2006
Innovative Financing Mechanism
The Air Ticket levy
Applied to all fights departing from countries
Amount can vary and decided by government• Around $US 1 domestic economy • Over $US 40 business international
Neutral (all companies)
= One adult or 2 child, life saving malaria
treatment One HIV test kit for a pregnant mother One week HIV treatment for a child One day of treatment for a patient on second
line combination One week first line TB treatment
Early stage product
development
Registration and policy for quality products
Global market
management
Reformulation and adaptation Delivery of
products
UNITAID only achieves impact by enable its partners
~$300M
Source: Partner survey, February 2011, n=31, UNITAID’s Strategy 2010-2012 Document, Dec 2009
Government, Pharma Companies, Gates Foundation, NGOs
$2B+
Global Fund, Bilaterals, World Bank, WHO
Country governments, NGOs$4B+
Market Impact Framework
Case for Intervention Pathway from market to public health impact
Public Health
ProblemIdentified
CommodityAccess
Issue&
Market Shortcomings
Identified
MarketIntervention
MarketImpact
-Local/int'l prcm't -price
- quality- availability
- delivery
PublicHealthImpact
UNITAID is one of several market playersCoordination is critical: Global Fund (including MDC), PEPFAR, PMI, USAID TB, WHO, Stop TB, UNAIDS, RBM, GDF, etc.
Demand(Buyers
and consumers)
Demand(Buyers
and consumers)
Non-UNITAID Interventions
UNITAIDInterventions
Market Shortcomings
Market Dynamics
Market Shortcomings
Supply(Sellers) Supply
(Sellers)
Policy, regulation, economics, guidelines, innovation, politics
www.unitaid.eu
Innovative spendingValue for Money
Money goes further– User friendly (FDC) Efficacy/Quality/Price– Transaction cost (below 4 per cent)
Investing in products of proven public health benefit• More medicines purchased and delivered
= more lives saved Creating and improving markets
• Incentives for manufactures to enter or develop market• Better prices negotiated – purchases made for many countries
high volumes• Market impact dimensions vary by product; can include:
– price, – quality, – availability and – timely delivery
Positive Externalities • Market benefits and results achieved by UNITAID available to all
Value for money
HIV-AIDS Medicines provision to low income countries
90% Generic
drugs
10% Branded Medicines
IndiaTRIPS2005
AfricaTRIPS
2014